Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index; none of the 14 sources its claims cite is checked for support yet.
Abstract
Background Eustachian tube dysfunction (ETD) and laryngopharyngeal reflux disease (LPRD) are under-recognized conditions that significantly impact quality of life. LPRD may contribute to ETD via gastric refluxate-induced mucosal damage. While proton pump inhibitors (PPIs) are commonly used for reflux management, their role in alleviating ETD symptoms remains controversial. This study investigates the association between LPRD and ETD and evaluates the efficacy of PPI therapy in ETD management. Methods A prospective study was conducted on patients diagnosed with ETD and LPRD. A total of 126 patients were included using consecutive non-randomized sampling. The participants underwent an eight-week regimen of twice-daily 40 mg oral omeprazole. ETD severity was assessed using the Eustachian Tube Dysfunction Questionnaire (ETDQ-7), while LPRD severity was measured via the Reflux Symptom Index (RSI) and Reflux Finding Score (RFS), both pre- and post-intervention. Independent t-tests and correlation analyses were performed to evaluate treatment outcomes. Results Significant reductions were observed in ETDQ-7 (16.20±10.47 to 10.40±5.47, p<0.001), RSI (11.42±7.65 to 4.50±2.65, p<0.001), and RFS (22.56±10.14 to 4.84±2.45, p<0.001) scores following PPI therapy, suggesting symptomatic improvement in both ETD and LPRD. Correlation analysis revealed a moderate association between both ETDQ-7 and RSI (0.346-0.391, p<0.001), and ETDQ-7 and RFS (0.437-0.515, p<0.001) scores respectively. However, residual symptoms in some patients suggest that additional pathophysiological factors may contribute to ETD beyond the reflux-mediated inflammation. Conclusion This study provides evidence supporting the link between LPRD and ETD and suggests that PPI therapy may alleviate ETD symptoms in a subset of patients. However, given the multifactorial nature of ETD, further studies are needed to explore alternative therapies (such as potassium channel blockers, Eustachian tube dilation, etc.) and long-term treatment outcomes.
Overview
CoChat Summary
TL;DR
In 110 adults with Eustachian tube dysfunction (ETD) and laryngopharyngeal reflux disease (LPRD) in Pakistan, eight weeks of omeprazole 40 mg twice daily significantly reduced ETDQ-7, RSI, and RFS scores. Moderate correlations between ETD and reflux scores support an LPRD–ETD link, but residual symptoms suggest ETD is multifactorial.
Key findings
- Of 126 enrolled patients, 110 completed follow-up; 70% were female, mean age was 34.2 ± 10.24 years, and baseline scores were ETDQ-7 16.2 ± 1.8, RSI 22.56 ± 6.23, and RFS 11.42 ± 3.76 (Table 1).
- After eight weeks of PPI therapy, ETDQ-7 decreased from 16.20 ± 10.47 to 10.40 ± 5.47 (p<0.001, r=0.518), RFS from 11.42 ± 7.65 to 4.50 ± 2.65 (p=0.014, r=0.233), and RSI from 22.56 ± 10.14 to 4.84 ± 2.45 (p<0.001, r=0.313) (Table 3).
- ETDQ-7 correlated with RSI and RFS before and after treatment: pre-treatment ETDQ-7 & RSI r=0.391, pre-treatment ETDQ-7 & RFS r=0.437, post-treatment ETDQ-7 & RSI r=0.346, and post-treatment ETDQ-7 & RFS r=0.515, all p<0.001 (Table 4).
- No significant gender differences or age/BMI associations were found for ETDQ-7, RSI, or RFS (p>0.05 for all comparisons; Table 2); residual symptoms in some patients suggest additional pathophysiological factors beyond reflux-mediated inflammation.
Methods
- Prospective observational study at Benazir Bhutto Hospital, Rawalpindi, Pakistan, over 12 months (August 2023–July 2024); 126 adults were recruited by non-probability consecutive sampling, with 110 in the final cohort after 16 (12.7%) were lost to follow-up.
- Inclusion criteria were age 18–60 years, clinical LPRD based on RSI/RFS, and ETD symptoms with ETDQ-7 ≥14.5; exclusions included prior ENT surgery affecting the Eustachian tube, acute/chronic ear disease, non-LPRD symptoms, smokers, allergies, and nonadherence. All participants received omeprazole 40 mg twice daily for eight weeks plus standard reflux management (dietary and lifestyle modifications), with ETDQ-7, RSI, and RFS administered at baseline and after eight weeks.
- Analysis used IBM SPSS v26; paired sample t-tests compared pre- and post-treatment scores, and Pearson correlation assessed relationships between ETDQ-7 and RSI/RFS scores, with p<0.05 considered significant.
Limitations
- The paper states: single-center design and reliance on subjective symptom scores may limit generalizability; non-random consecutive sampling and lack of a control group introduce potential bias; the eight-week follow-up precludes assessment of long-term outcomes.
- Evident from the text: the abstract and results tables inconsistently label/order RSI and RFS values (e.g., abstract reports RSI 11.42→4.50 and RFS 22.56→4.84, while Table 3 reports RFS 11.42→4.50 and RSI 22.56→4.84), and baseline SDs differ between Table 1 and Table 3, complicating interpretation.
- Evident from the text: the pre-post observational design without a control group cannot establish causality between PPI therapy and ETD symptom improvement.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 25 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Significant reductions were observed in ETDQ-7 (16.20±10.47 to 10.40±5.47, p<0.001)”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| RFS | 11.42±7.65 | 4.50±2.65 | 2.51 | 0.014 | 0.233 |”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At baseline, all participants had clinically significant ETD (ETDQ-7 ≥14.5; mean score: 16.2 ± 1.8).”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
plainn = 110- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| Pre-treatment ETDQ-7 & RFS | (16.20±10.47) & (11.42±7.65) | 0.437 | p<0.001 |”
- Also stated in: § Results · plain
“| Post-treatment ETDQ-7 & RFS | (10.40±5.47) & (4.50±2.65) | 0.515 | p<0.001 |”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“LPRD was also confirmed, with mean RSI and RFS scores of 22.56 ± 6.23 and 11.42 ± 3.76, respectively (Table 1).”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
plainn = 110- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
17 more claims
Create a free account to see all 34 claims and to verify the 14 references still open.
- The quote only partly states this claim. 1
- Probably not a substantial claim. 5
- It may state two separate claims as one. 7
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| Baseline RFS Score | 11.42±3.76 |”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| RFS | 11.42±7.65 | 4.50±2.65 | 2.51 | 0.014 | 0.233 |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| Baseline ETDQ-7 Score | 16.2±1.8 |”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| ETDQ-7 | 16.20±10.47 | 10.40±5.47 | 6.32 | <0.001 | 0.518 |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Abstract
“RFS (22.56±10.14 to 4.84±2.45, p<0.001)”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| RFS | 11.42±7.65 | 4.50±2.65 | 2.51 | 0.014 | 0.233 |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| Baseline RSI Score | 22.56±6.23 |”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| RSI | 22.56±10.14 | 4.84±2.45 | 3.44 | <0.001 | 0.313 |”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Abstract
“RSI (11.42±7.65 to 4.50±2.65, p<0.001), and RFS (22.56±10.14 to 4.84±2.45, p<0.001)”
§ Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting > Results
“| RFS | 11.42±7.65 | 4.50±2.65 | 2.51 | 0.014 | 0.233 | | RSI | 22.56±10.14 | 4.84±2.45 | 3.44 | <0.001 | 0.313 |”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
Koufman, J. A. (1991) · The Laryngoscope · doi:10.1002/lary.1991.101.s53.1 · Cited by 1,647
Schilder, A. G. M., Chonmaitree, T., Cripps, A. W., Rosenfeld, R. M., Casselbrant, M. L., Haggard, M. P., & Venekamp, R. P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.63 · Cited by 577
McCoul, E. D., Anand, V. K., & Christos, P. J. (2012) · The Laryngoscope · doi:10.1002/lary.23223 · Cited by 331
Schröder, S., Lehmann, M., Sauzet, O., Ebmeyer, J., & Sudhoff, H. (2015) · The Laryngoscope · doi:10.1002/lary.24922 · Cited by 142 · cited 1×
“Although tools like the Eustachian Tube Dysfunction Questionnaire (ETDQ-7) and the Reflux Symptom Index (RSI) have been validated for diagnosing these conditions in controlled environments, their real-world applicability in low-resource settings is rarely studied [8,9].”
Extra-Esophageal Manifestations of Gastroesophageal Reflux Disease: Diagnosis and Treatment
Hom, C., & Vaezi, M. F. (2013) · Drugs · doi:10.1007/s40265-013-0101-8 · Cited by 109
Association Between Laryngopharyngeal Reflux and Media Otitis: A Systematic Review
Lechien, J. R., Hans, S., Simon, F., Horoi, M., Calvo-Henriquez, C., Chiesa-Estomba, C. M., Mayo-Yáñez, M., Bartel, R., Piersiala, K., Nguyen, Y., et al. (2021) · Otology & Neurotology · doi:10.1097/mao.0000000000003123 · Cited by 56
Review of management of laryngopharyngeal reflux disease
Lechien, J.-R., Mouawad, F., Bobin, F., Bartaire, E., Crevier-Buchman, L., & Saussez, S. (2021) · European Annals of Otorhinolaryngology, Head and Neck Diseases · doi:10.1016/j.anorl.2020.11.002 · Cited by 51
Liu, D., Qian, T., Sun, S., & Jiang, J. J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s282809 · Cited by 32
Role of laryngopharyngeal reflux in the pathogenesis of otitis media with effusion
Dengiz, R., Arıkan, O. K., Kuran, G., Haytoğlu, S., & Doğru, M. (2019) · The Journal of International Advanced Otology · doi:10.5152/iao.2015.642 · Cited by 30
Zhen, Z., Zhao, T., Wang, Q., Zhang, J., & Zhong, Z. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1024743 · Cited by 22
Cited by
Eustachian Tube Dysfunction in Hearing Loss: Mechanistic Pathways to Targeted Interventions
Kim, H. (2025) · Biomedicines · doi:10.3390/biomedicines13112686 · Cited by 8
Alternative Causes of Obstructive Eustachian Tube Dysfunction
Saxby, A. J., Jufas, N. E., Kong, J. H. K., & Patel, N. P. (2026) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2026.03.001
Role of Laryngopharyngeal Reflux Disease in Eustachian Tube Dysfunction: A Systematic Review
Lechien, J. R., & Maniaci, A. (2026) · Journal of Voice · doi:10.1016/j.jvoice.2026.09.005
Raditya, I. G. W. A. (2026) · Sriwijaya Journal of Otorhinolaryngology · doi:10.59345/sjorl.v4i2.340
Metadata
- Authors
- Ahmad, M. T., Farooq, U., Akram, A., Naqvi, S. H. B., Maheen, M., Haider, A., Nashwan, A. J., Maqbool, S., & Rehman, A.
- Affiliations
- Benazir Bhutto Hospital (PK)
- Rawalpindi Medical University (PK)
- Nishtar Medical College and Hospital (PK)
- Hamdard University (PK)
- Hamad Medical Corporation (QA)
- Corresponding author
- Nashwan, Abdulqadir J
- Venue
- Cureus
- Published
- 2025-05-11
- Volume
- 17
- Issue
- 5
- Pages
- e83896-e83896
- ISSN
- 2168-8184 (ISSN-L)
- PMC
- PMC12152232
- OpenAlex
- W4410271170
- Semantic Scholar
- 945f27956e3bd110dcbead279aff22748a854b34
- Cited by
- 4
- References
- 13
- Citations by year
- 2026: 3 · 2025: 1
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Cureus (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Ear Surgery and Otitis Media
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- laryngopharyngeal reflux, Eustachian tube dysfunction, proton pump inhibitors, omeprazole, reflux symptom index, reflux finding score, resource-limited settings, treatment efficacy, quality of life, potassium channel blockers, cost-effectiveness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting. https://app.cochat.ai/papers/10.7759/cureus.83896
- The paper
- Ahmad, M. T., Farooq, U., Akram, A., Naqvi, S. H. B., Maheen, M., Haider, A., Nashwan, A. J., Maqbool, S., & Rehman, A. (2025). Exploring the Role of Laryngopharyngeal Reflux in Eustachian Tube Dysfunction: Therapeutic Potential of Proton Pump Inhibitors in a Resource-Constrained Setting. Cureus. https://doi.org/10.7759/cureus.83896
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
